Bernard Kelley Unloaded $169,255 Worth of Codexis, Inc. (CDXS) Shares; Home Capital Group Inc. (TSE:HCG) Had 1 Analysts Last Week

June 23, 2018 - By Dolores Ford

Codexis, Inc. (NASDAQ:CDXS) Logo

Among 5 analysts covering Home Capital Group Inc. (TSE:HCG), 1 have Buy rating, 0 Sell and 4 Hold. Therefore 20% are positive. Home Capital Group Inc. had 37 analyst reports since July 28, 2015 according to SRatingsIntel. The firm has “Sector Perform” rating given on Friday, February 10 by Scotia Capital. The stock of Home Capital Group Inc. (TSE:HCG) has “Hold” rating given on Friday, June 30 by TD Securities. The company was maintained on Tuesday, December 8 by RBC Capital Markets. The rating was maintained by Scotia Capital on Friday, April 21 with “Sector Perform”. The stock has “Outperform” rating by Raymond James on Friday, February 10. The rating was maintained by Raymond James on Friday, October 28 with “Outperform”. The stock of Home Capital Group Inc. (TSE:HCG) earned “Sector Perform” rating by RBC Capital Markets on Thursday, June 15. TD Securities upgraded Home Capital Group Inc. (TSE:HCG) on Friday, January 22 to “Buy” rating. As per Wednesday, June 21, the company rating was upgraded by IA Securities. The rating was maintained by Scotia Capital with “Sector Outperform” on Friday, July 31. See Home Capital Group Inc. (TSE:HCG) latest ratings:

Codexis, Inc. (NASDAQ:CDXS) Ratings Coverage

Among 6 analysts covering Codexis (NASDAQ:CDXS), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Codexis has $18 highest and $3.75 lowest target. $10.96’s average target is -30.85% below currents $15.85 stock price. Codexis had 11 analyst reports since August 12, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Wednesday, August 26 by Zacks. First Analysis downgraded Codexis, Inc. (NASDAQ:CDXS) on Thursday, January 26 to “Equal-Weight” rating. Jefferies maintained the stock with “Buy” rating in Friday, October 13 report. The firm earned “Buy” rating on Wednesday, May 16 by Stephens. H.C. Wainwright initiated Codexis, Inc. (NASDAQ:CDXS) rating on Wednesday, January 6. H.C. Wainwright has “Buy” rating and $6 target. On Wednesday, August 12 the stock rating was downgraded by Zacks to “Hold”. The stock of Codexis, Inc. (NASDAQ:CDXS) earned “Buy” rating by Ladenburg Thalmann on Wednesday, January 4. The rating was maintained by H.C. Wainwright on Monday, March 12 with “Buy”.

Investors sentiment decreased to 1.34 in 2018 Q1. Its down 0.83, from 2.17 in 2017Q4. It fall, as 9 investors sold Codexis, Inc. shares while 20 reduced holdings. 16 funds opened positions while 23 raised stakes. 28.16 million shares or 0.51% more from 28.02 million shares in 2017Q4 were reported. Trexquant Lp holds 0.01% or 13,466 shares. Moreover, White Pine Capital Limited Liability Co has 0.22% invested in Codexis, Inc. (NASDAQ:CDXS) for 54,040 shares. Renaissance Technologies holds 116,400 shares. Finance Architects accumulated 0.02% or 8,516 shares. Baillie Gifford & stated it has 0.03% in Codexis, Inc. (NASDAQ:CDXS). Ameriprise holds 0% or 125,800 shares in its portfolio. State Board Of Administration Of Florida Retirement System holds 44,892 shares. Envestnet Asset Incorporated has 0% invested in Codexis, Inc. (NASDAQ:CDXS) for 2,039 shares. Cortina Asset Mgmt Ltd Liability Com has 0.28% invested in Codexis, Inc. (NASDAQ:CDXS) for 516,030 shares. Bankshares Of Montreal Can stated it has 1,500 shares. Eam Investors Limited Liability Co holds 166,272 shares. Germany-based Deutsche Bank Ag has invested 0% in Codexis, Inc. (NASDAQ:CDXS). State Street Corporation reported 664,542 shares stake. Blair William And Il owns 143,794 shares for 0.01% of their portfolio. Atlantic Group Llc accumulated 0% or 500 shares.

The stock increased 0.32% or $0.05 during the last trading session, reaching $15.85. About 490,290 shares traded or 21.02% up from the average. Codexis, Inc. (NASDAQ:CDXS) has risen 215.91% since June 23, 2017 and is uptrending. It has outperformed by 203.34% the S&P500. Some Historical CDXS News: 08/03/2018 Codexis 4Q EPS 2c; 14/05/2018 – Fidelity Management & Research Exits Position in Codexis; 08/03/2018 – CODEXIS INC SEES 2018 GROSS MARGIN ON PRODUCT SALES IS EXPECTED TO BE 45% TO 48%; 23/04/2018 – Porton Pharma Solutions and Codexis Launch Global Partnership; 08/03/2018 – Codexis 4Q Adj EPS 6c; 23/04/2018 – PORTON PHARMA SOLUTIONS & CODEXIS LAUNCH GLOBAL PARTNERSHIP; 10/05/2018 – Codexis 1Q Loss/Shr 10c; 30/05/2018 – Codexis Presenting at KeyCorp Conference Tomorrow; 08/03/2018 – CODEXIS INC CDXS.O SEES FY 2018 REVENUE $60 MLN TO $63 MLN; 08/03/2018 – Codexis Sees 2018 Rev $60M-$63M

The director of Codexis Inc, Bernard Kelley is in the stock market news today. It was shown in a public document filled by Bernard Kelley and submitted to the U.S. Security and Exchange Commission on June 22, 2018, he sold 10,206 shares from the public company having a market value of $169,255 U.S. Dollars. The shares average price was $16.6. Bernard Kelley presently has ownership of 225,668 shares or 0.42% of Codexis Inc’s market cap.

Analysts await Codexis, Inc. (NASDAQ:CDXS) to report earnings on August, 8. They expect $-0.13 EPS, 0.00% or $0.00 from last year’s $-0.13 per share. After $-0.10 actual EPS reported by Codexis, Inc. for the previous quarter, Wall Street now forecasts 30.00% negative EPS growth.

Codexis, Inc. discovers, develops, and sells protein catalysts. The company has market cap of $843.86 million. It also offers intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable clients to perform chemistry screening. It currently has negative earnings. The firm also provides protein catalyst screening and protein engineering services.

Since March 21, 2018, it had 0 insider purchases, and 12 selling transactions for $3.11 million activity. The insider Aldridge Michael D. sold $283,945. $259,828 worth of Codexis, Inc. (NASDAQ:CDXS) was sold by NICOLS JOHN J. 41,666 shares were sold by WOLF DENNIS P, worth $464,384 on Monday, March 26. Lalonde James also sold $259,930 worth of Codexis, Inc. (NASDAQ:CDXS) shares. 18,736 Codexis, Inc. (NASDAQ:CDXS) shares with value of $264,307 were sold by SANGSTER GORDON. Cheng Pam P. sold $549,782 worth of Codexis, Inc. (NASDAQ:CDXS) on Monday, May 21. Shares for $124,683 were sold by KELLEY BERNARD J on Wednesday, March 21.

More notable recent Codexis, Inc. (NASDAQ:CDXS) news were published by: Globenewswire.com which released: “Codexis to Present at Three Upcoming Investment Conferences” on May 29, 2018, also Fool.com with their article: “3 Growth Stocks I’d Buy Right Now” published on June 21, 2018, Nasdaq.com published: “New Research Coverage Highlights WPP, Codexis, Natural Resource Partners LP, Mercer International, Booking, and ..” on June 01, 2018. More interesting news about Codexis, Inc. (NASDAQ:CDXS) were released by: Fool.com and their article: “3 Stocks That Could Put Tesla’s Returns to Shame” published on June 16, 2018 as well as Benzinga.com‘s news article titled: “Benzinga’s Top Upgrades, Downgrades For June 19, 2018” with publication date: June 19, 2018.

The stock increased 0.07% or $0.01 during the last trading session, reaching $15. About 95,300 shares traded. Home Capital Group Inc. (TSE:HCG) has 0.00% since June 23, 2017 and is . It has underperformed by 12.57% the S&P500.

Another recent and important Home Capital Group Inc. (TSE:HCG) news was published by Equitiesfocus.com which published an article titled: “Home Capital Group Inc (HCG) Director Purchases C$86280.00 in Stock” on June 10, 2018.

Codexis, Inc. (NASDAQ:CDXS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: